nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Parkinson's disease	0.775	1	CbGaD
Naltrexone—OPRM1—telencephalic ventricle—Parkinson's disease	0.0103	0.164	CbGeAlD
Naltrexone—OPRM1—nerve—Parkinson's disease	0.0065	0.104	CbGeAlD
Naltrexone—OPRD1—forebrain—Parkinson's disease	0.00395	0.0629	CbGeAlD
Naltrexone—OPRK1—forebrain—Parkinson's disease	0.00379	0.0603	CbGeAlD
Naltrexone—OPRM1—brainstem—Parkinson's disease	0.00279	0.0445	CbGeAlD
Naltrexone—OPRM1—forebrain—Parkinson's disease	0.00269	0.0429	CbGeAlD
Naltrexone—OPRD1—head—Parkinson's disease	0.00226	0.036	CbGeAlD
Naltrexone—OPRK1—head—Parkinson's disease	0.00217	0.0345	CbGeAlD
Naltrexone—OPRD1—nervous system—Parkinson's disease	0.00214	0.0342	CbGeAlD
Naltrexone—OPRD1—central nervous system—Parkinson's disease	0.00206	0.0329	CbGeAlD
Naltrexone—OPRK1—nervous system—Parkinson's disease	0.00206	0.0327	CbGeAlD
Naltrexone—OPRK1—central nervous system—Parkinson's disease	0.00198	0.0315	CbGeAlD
Naltrexone—OPRK1—cerebellum—Parkinson's disease	0.00193	0.0308	CbGeAlD
Naltrexone—OPRM1—midbrain—Parkinson's disease	0.00178	0.0283	CbGeAlD
Naltrexone—OPRM1—spinal cord—Parkinson's disease	0.00174	0.0276	CbGeAlD
Naltrexone—Methylnaltrexone—CYP2D6—Parkinson's disease	0.00167	0.177	CrCbGaD
Naltrexone—OPRD1—brain—Parkinson's disease	0.00164	0.0261	CbGeAlD
Naltrexone—OPRK1—brain—Parkinson's disease	0.00157	0.025	CbGeAlD
Naltrexone—OPRM1—head—Parkinson's disease	0.00154	0.0246	CbGeAlD
Naltrexone—OPRM1—nervous system—Parkinson's disease	0.00146	0.0233	CbGeAlD
Naltrexone—OPRM1—central nervous system—Parkinson's disease	0.00141	0.0224	CbGeAlD
Naltrexone—Oxymorphone—CYP2D6—Parkinson's disease	0.00124	0.132	CrCbGaD
Naltrexone—OPRM1—brain—Parkinson's disease	0.00112	0.0178	CbGeAlD
Naltrexone—Hydrocodone—CYP2D6—Parkinson's disease	0.00109	0.115	CrCbGaD
Naltrexone—Oxycodone—CYP2D6—Parkinson's disease	0.000991	0.105	CrCbGaD
Naltrexone—Buprenorphine—CYP2D6—Parkinson's disease	0.000913	0.097	CrCbGaD
Naltrexone—Hydromorphone—CYP2D6—Parkinson's disease	0.0009	0.0956	CrCbGaD
Naltrexone—ABCB1—embryo—Parkinson's disease	0.000878	0.014	CbGeAlD
Naltrexone—ABCB1—forebrain—Parkinson's disease	0.000777	0.0124	CbGeAlD
Naltrexone—Morphine—CYP2D6—Parkinson's disease	0.000765	0.0813	CrCbGaD
Naltrexone—ABCB1—cardiovascular system—Parkinson's disease	0.000657	0.0105	CbGeAlD
Naltrexone—Buprenorphine—ABCB1—Parkinson's disease	0.000652	0.0693	CrCbGaD
Naltrexone—Naloxone—ABCB1—Parkinson's disease	0.000647	0.0688	CrCbGaD
Naltrexone—ABCB1—medulla oblongata—Parkinson's disease	0.000561	0.00894	CbGeAlD
Naltrexone—Morphine—ABCB1—Parkinson's disease	0.000546	0.0581	CrCbGaD
Naltrexone—ABCB1—midbrain—Parkinson's disease	0.000513	0.00817	CbGeAlD
Naltrexone—ABCB1—spinal cord—Parkinson's disease	0.000501	0.00797	CbGeAlD
Naltrexone—ABCB1—head—Parkinson's disease	0.000445	0.00709	CbGeAlD
Naltrexone—ABCB1—nervous system—Parkinson's disease	0.000422	0.00672	CbGeAlD
Naltrexone—ABCB1—central nervous system—Parkinson's disease	0.000406	0.00647	CbGeAlD
Naltrexone—ABCB1—cerebellum—Parkinson's disease	0.000397	0.00632	CbGeAlD
Naltrexone—ABCB1—brain—Parkinson's disease	0.000322	0.00513	CbGeAlD
Naltrexone—OPRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000202	0.00132	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000201	0.00131	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NDUFB11—Parkinson's disease	0.0002	0.00131	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—EDN1—Parkinson's disease	0.000199	0.0013	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000198	0.00129	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000198	0.00129	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	0.000197	0.00129	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.000196	0.00128	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000196	0.00128	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000196	0.00128	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000194	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GPR37—Parkinson's disease	0.000193	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DGKQ—Parkinson's disease	0.000193	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PDYN—Parkinson's disease	0.000193	0.00126	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000192	0.00125	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GCH1—Parkinson's disease	0.000191	0.00125	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.000188	0.00123	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.000184	0.00121	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.000184	0.00121	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00018	0.00117	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—GRM5—Parkinson's disease	0.000179	0.00117	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000178	0.00117	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000177	0.00116	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RIT2—Parkinson's disease	0.000176	0.00115	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—EDN1—Parkinson's disease	0.000175	0.00114	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000174	0.00114	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000174	0.00114	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GBA—Parkinson's disease	0.00017	0.00111	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—FBP1—Parkinson's disease	0.00017	0.00111	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DBH—Parkinson's disease	0.00017	0.00111	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00017	0.00111	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000168	0.0011	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GRK5—Parkinson's disease	0.000167	0.00109	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000167	0.00109	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000166	0.00109	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000164	0.00107	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000164	0.00107	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000164	0.00107	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000163	0.00107	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000161	0.00105	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.00016	0.00104	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000156	0.00102	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RIT2—Parkinson's disease	0.000155	0.00101	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000153	0.001	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000153	0.000998	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000152	0.000992	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000151	0.000987	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GRM4—Parkinson's disease	0.00015	0.000981	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00015	0.000978	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TAC1—Parkinson's disease	0.000149	0.000972	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000148	0.000966	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GRK5—Parkinson's disease	0.000147	0.000959	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD1—Parkinson's disease	0.000146	0.000954	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000146	0.000953	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000145	0.00095	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000144	0.000939	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PENK—Parkinson's disease	0.000142	0.00093	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAG—Parkinson's disease	0.000142	0.00093	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000142	0.000929	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000142	0.000929	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000142	0.000928	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000142	0.000926	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD3—Parkinson's disease	0.000141	0.000924	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000141	0.000921	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000141	0.00092	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000141	0.00092	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00014	0.000914	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000136	0.000892	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000132	0.000866	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000132	0.000862	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GRM4—Parkinson's disease	0.000132	0.00086	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000131	0.000855	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TAC1—Parkinson's disease	0.00013	0.000853	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDYN—Parkinson's disease	0.00013	0.00085	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000129	0.000845	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000129	0.000843	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD1—Parkinson's disease	0.000128	0.000836	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR7—Parkinson's disease	0.000128	0.000835	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD2—Parkinson's disease	0.000128	0.000835	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000127	0.000833	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DDC—Parkinson's disease	0.000125	0.000816	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PENK—Parkinson's disease	0.000125	0.000815	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAG—Parkinson's disease	0.000125	0.000815	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000124	0.000812	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000124	0.00081	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD3—Parkinson's disease	0.000124	0.00081	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000123	0.000807	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000123	0.000807	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000123	0.000806	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GFAP—Parkinson's disease	0.000122	0.0008	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000121	0.000794	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GRM5—Parkinson's disease	0.000121	0.000791	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000119	0.000778	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTA4—Parkinson's disease	0.000118	0.000771	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000116	0.000756	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000115	0.000754	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDYN—Parkinson's disease	0.000114	0.000746	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000113	0.000736	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD2—Parkinson's disease	0.000112	0.000732	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR7—Parkinson's disease	0.000112	0.000732	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000112	0.000732	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000111	0.000727	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.00011	0.000721	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000108	0.000707	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000108	0.000704	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GFAP—Parkinson's disease	0.000107	0.000701	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PLA2G6—Parkinson's disease	0.000106	0.000694	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGF20—Parkinson's disease	0.000106	0.000693	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GRM5—Parkinson's disease	0.000106	0.000693	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PENK—Parkinson's disease	0.000105	0.000689	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAG—Parkinson's disease	0.000105	0.000689	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOB—Parkinson's disease	0.000105	0.000687	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000105	0.000684	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000104	0.000682	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000104	0.000682	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000104	0.00068	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000103	0.000673	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ND3—Parkinson's disease	0.000103	0.000673	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000103	0.000673	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000103	0.000672	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—EDN1—Parkinson's disease	0.000102	0.000669	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—EDN1—Parkinson's disease	9.87e-05	0.000646	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	9.85e-05	0.000644	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	9.77e-05	0.000639	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TALDO1—Parkinson's disease	9.68e-05	0.000633	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—OMD—Parkinson's disease	9.68e-05	0.000633	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	9.64e-05	0.00063	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.57e-05	0.000626	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INSR—Parkinson's disease	9.49e-05	0.00062	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	9.46e-05	0.000619	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	9.46e-05	0.000619	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGF20—Parkinson's disease	9.3e-05	0.000608	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NDUFB11—Parkinson's disease	9.17e-05	0.0006	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	9.06e-05	0.000593	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADORA2A—Parkinson's disease	9.01e-05	0.000589	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—EDN1—Parkinson's disease	8.97e-05	0.000586	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGB—Parkinson's disease	8.97e-05	0.000586	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	8.96e-05	0.000586	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—Parkinson's disease	8.95e-05	0.000585	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR1A—Parkinson's disease	8.92e-05	0.000583	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TAC1—Parkinson's disease	8.78e-05	0.000574	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GCH1—Parkinson's disease	8.75e-05	0.000572	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—Parkinson's disease	8.64e-05	0.000565	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD1—Parkinson's disease	8.61e-05	0.000563	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	8.34e-05	0.000546	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	8.34e-05	0.000546	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INSR—Parkinson's disease	8.32e-05	0.000544	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGB—Parkinson's disease	7.86e-05	0.000514	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	7.86e-05	0.000514	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	7.84e-05	0.000513	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	7.82e-05	0.000511	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYP2D6—Parkinson's disease	7.81e-05	0.000511	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—FBP1—Parkinson's disease	7.8e-05	0.00051	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DBH—Parkinson's disease	7.8e-05	0.00051	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GBA—Parkinson's disease	7.8e-05	0.00051	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	7.79e-05	0.000509	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	7.7e-05	0.000504	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CTGF—Parkinson's disease	7.66e-05	0.000501	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	7.62e-05	0.000498	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	7.58e-05	0.000496	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	7.55e-05	0.000494	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	7.54e-05	0.000493	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	7.54e-05	0.000493	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	7.32e-05	0.000478	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	7.3e-05	0.000477	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYP2E1—Parkinson's disease	7.14e-05	0.000467	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NQO1—Parkinson's disease	7.06e-05	0.000462	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INSR—Parkinson's disease	7.03e-05	0.00046	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.99e-05	0.000457	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TH—Parkinson's disease	6.96e-05	0.000455	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	6.83e-05	0.000447	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.82e-05	0.000446	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYCS—Parkinson's disease	6.68e-05	0.000437	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGB—Parkinson's disease	6.64e-05	0.000435	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	6.63e-05	0.000434	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	6.62e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	6.62e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	6.61e-05	0.000432	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.54e-05	0.000428	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	6.51e-05	0.000426	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.42e-05	0.00042	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	6.38e-05	0.000417	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	6.32e-05	0.000413	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	6.18e-05	0.000404	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	6.11e-05	0.0004	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	6.04e-05	0.000395	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—COMT—Parkinson's disease	5.92e-05	0.000387	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTP1—Parkinson's disease	5.89e-05	0.000385	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOA—Parkinson's disease	5.88e-05	0.000384	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—HMOX1—Parkinson's disease	5.81e-05	0.00038	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	5.77e-05	0.000378	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DDC—Parkinson's disease	5.73e-05	0.000374	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.69e-05	0.000372	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	5.59e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	5.59e-05	0.000366	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ABCB1—Parkinson's disease	5.57e-05	0.000365	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NGF—Parkinson's disease	5.55e-05	0.000363	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	5.54e-05	0.000363	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTM1—Parkinson's disease	5.41e-05	0.000354	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.41e-05	0.000354	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	5.36e-05	0.000351	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	5.3e-05	0.000346	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	5.28e-05	0.000346	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GPX1—Parkinson's disease	5.18e-05	0.000339	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.08e-05	0.000332	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APOE—Parkinson's disease	4.91e-05	0.000321	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.87e-05	0.000318	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NGF—Parkinson's disease	4.87e-05	0.000318	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOB—Parkinson's disease	4.82e-05	0.000315	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MTHFR—Parkinson's disease	4.78e-05	0.000313	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	4.69e-05	0.000306	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	4.63e-05	0.000303	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	4.53e-05	0.000296	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	4.48e-05	0.000293	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—APOE—Parkinson's disease	4.45e-05	0.000291	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APOE—Parkinson's disease	4.31e-05	0.000282	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INS—Parkinson's disease	4.2e-05	0.000274	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NGF—Parkinson's disease	4.11e-05	0.000269	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.92e-05	0.000256	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—INS—Parkinson's disease	3.8e-05	0.000249	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INS—Parkinson's disease	3.68e-05	0.000241	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOE—Parkinson's disease	3.64e-05	0.000238	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.58e-05	0.000234	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CTGF—Parkinson's disease	3.52e-05	0.00023	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.28e-05	0.000214	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NQO1—Parkinson's disease	3.24e-05	0.000212	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TH—Parkinson's disease	3.19e-05	0.000209	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	3.12e-05	0.000204	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INS—Parkinson's disease	3.11e-05	0.000203	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	3.1e-05	0.000203	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYCS—Parkinson's disease	3.06e-05	0.0002	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.87e-05	0.000188	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	2.74e-05	0.000179	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	2.72e-05	0.000178	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—COMT—Parkinson's disease	2.71e-05	0.000178	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.7e-05	0.000177	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOA—Parkinson's disease	2.7e-05	0.000176	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.66e-05	0.000174	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	2.52e-05	0.000165	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.48e-05	0.000162	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GPX1—Parkinson's disease	2.38e-05	0.000155	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	2.32e-05	0.000151	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	2.3e-05	0.00015	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.19e-05	0.000143	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	2.13e-05	0.000139	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOE—Parkinson's disease	2.04e-05	0.000134	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—Parkinson's disease	1.83e-05	0.00012	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—INS—Parkinson's disease	1.74e-05	0.000114	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—Parkinson's disease	1.61e-05	0.000105	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—Parkinson's disease	1.36e-05	8.89e-05	CbGpPWpGaD
